Skip to content
healthcare.dev

Cholestyramine

NDC 33342-319, Cholestyramine, powder, for suspension, from Macleods Pharmaceuticals Limited.

Product NDC
33342-319
Status
Listed
Labeler
Macleods Pharmaceuticals Limited
Dosage form
POWDER, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209109
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/33342-319 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CHOLESTYRAMINE4 g/5.7g

Pharmacologic classes

Bile Acid Sequestrant [EPC]; Bile-acid Binding Activity [MoA]

Package NDCNDC-11Package
33342-319-703334203197060 POUCH in 1 CARTON (33342-319-70) / 5.7 g in 1 POUCH (33342-319-01)
33342-319-723334203197242 POUCH in 1 CARTON (33342-319-72) / 5.7 g in 1 POUCH (33342-319-01)
33342-319-8333342031983239.4 g in 1 JAR (33342-319-83)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c41529f1-16d2-4ca3-91eb-f809571f5ae3

Use it

Look up 33342-319 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/33342-319 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 33342-319. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.